Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).

@article{Murakami1996HepatocellularCM,
  title={Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).},
  author={Takamichi Murakami and Richard L. Baron and Mark S. Peterson and Julian Holland Oliver and Peter L. Davis and Sheri R. Confer and Michael P Federle},
  journal={Radiology},
  year={1996},
  volume={200 1},
  pages={69-77}
}
PURPOSE To determine the efficacy of manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate) (DPDP) at magnetic resonance (MR) imaging for evaluation of hepatocellular carcinoma (HCC). MATERIALS AND METHODS MR imaging at 1.5 T was performed in 20 patients with 65 HCC nodules. T1- and T2-weighted spin-echo and T1-weighted gradient-recalled-echo images were obtained before and after administration of 5 mumol/kg Mn-DPDP. Readers individually evaluated the pre- and… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 25 extracted citations

Contrast agents for hepatic MRI

Cancer imaging : the official publication of the International Cancer Imaging Society • 2007
View 1 Excerpt

MRI in detection of hepatocellular carcinoma (HCC)

Cancer imaging : the official publication of the International Cancer Imaging Society • 2005

Similar Papers

Loading similar papers…